Evidence map›Paper›PMID 26567339›Full record

ArticleThe Journal of biological chemistry2016

Identification of Critical Paraoxonase 1 Residues Involved in High Density Lipoprotein Interaction.

Xiaodong Gu, Ying Huang, Bruce S Levison, Gary Gerstenecker, Anthony J DiDonato, Leah B Hazen, Joonsue Lee, Valentin Gogonea, Joseph A DiDonato, Stanley L Hazen

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Mutual Influences between Nitric Oxide and Paraoxonase 1.Antioxidants (Basel, Switzerland) · 2019
    Review
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Xiaodong GuFrom the Department of Cellular and Molecular Medicine, Center for Cardiovascular Diagnostics and Prevention, and.
Ying HuangFrom the Department of Cellular and Molecular Medicine, Center for Cardiovascular Diagnostics and Prevention, and.
Bruce S LevisonFrom the Department of Cellular and Molecular Medicine, Center for Cardiovascular Diagnostics and Prevention, and.
Gary Gersteneckerthe Department of Chemistry, Cleveland State University, Cleveland, Ohio 44115.
Anthony J DiDonatoFrom the Department of Cellular and Molecular Medicine, Center for Cardiovascular Diagnostics and Prevention, and.
Leah B HazenFrom the Department of Cellular and Molecular Medicine, Center for Cardiovascular Diagnostics and Prevention, and. Electronic address: hazens@ccf.org.
Joonsue LeeFrom the Department of Cellular and Molecular Medicine, Center for Cardiovascular Diagnostics and Prevention, and.
Valentin GogoneaFrom the Department of Cellular and Molecular Medicine, Center for Cardiovascular Diagnostics and Prevention, and; the Department of Chemistry, Cleveland State University, Cleveland, Ohio 44115.
Joseph A DiDonatoFrom the Department of Cellular and Molecular Medicine, Center for Cardiovascular Diagnostics and Prevention, and.
Stanley L HazenFrom the Department of Cellular and Molecular Medicine, Center for Cardiovascular Diagnostics and Prevention, and; Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195 and.
Cleveland State University · USCleveland Clinic · US

Funding

Structural Determinants Of Ceruloplasmin Inflammatory ActivityP01HL076491 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI PLOW, EDWARD FRANKLIN · 2004 to 2019
$27.3M
Targeting pathological hyaluronan matricesP01HL103453 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI REIZES, OFER · 2011 to 2020
$26.8M
Airway redox biochemistry as a deteriminant of asthma phenotype during adolescen*U10HL109250 · NHLBI · UNIVERSITY OF VIRGINIA · PI ERZURUM, SERPIL C., GASTON, BENJAMIN · 2011 to 2016
$4.2M
NHLBI NIH HHS P01 HL076491NHLBI NIH HHS P01 HL103453NHLBI NIH HHS U10 HL109250
6 · The paper itself

Abstract

Paraoxonase 1 (PON1) is a high density lipoprotein (HDL)-associated protein with atherosclerosis-protective and systemic anti-oxidant functions. We recently showed that PON1, myeloperoxidase, and HDL bind to one another in vivo forming a functional ternary complex (Huang, Y., Wu, Z., Riwanto, M., Gao, S., Levison, B. S., Gu, X., Fu, X., Wagner, M. A., Besler, C., Gerstenecker, G., Zhang, R., Li, X. M., Didonato, A. J., Gogonea, V., Tang, W. H., et al. (2013) J. Clin. Invest. 123, 3815-3828). However, specific residues on PON1 involved in the HDL-PON1 interaction remain unclear. Unambiguous identification of protein residues involved in docking interactions to lipid surfaces poses considerable methodological challenges. Here we describe a new strategy that uses a novel synthetic photoactivatable and click chemistry-taggable phospholipid probe, which, when incorporated into HDL, was used to identify amino acid residues on PON1 that directly interact with the lipoprotein phospholipid surface. Several specific PON1 residues (Leu-9, Tyr-185, and Tyr-293) were identified through covalent cross-links with the lipid probes using affinity isolation coupled to liquid chromatography with on-line tandem mass spectrometry. Based upon the crystal structure for PON1, the identified residues are all localized in relatively close proximity on the surface of PON1, defining a domain that binds to the HDL lipid surface. Site-specific mutagenesis of the identified PON1 residues (Leu-9, Tyr-185, and Tyr-293), coupled with functional studies, reveals their importance in PON1 binding to HDL and both PON1 catalytic activity and stability. Specifically, the residues identified on PON1 provide important structural insights into the PON1-HDL interaction. More generally, the new photoactivatable and affinity-tagged lipid probe developed herein should prove to be a valuable tool for identifying contact sites supporting protein interactions with lipid interfaces such as found on cell membranes or lipoproteins.

Indexed as

Amino Acid MotifsApolipoprotein A-IAryldialkylphosphataseCatalysisCrystallography, X-RayHumansLipoproteins, HDLMutagenesis, Site-DirectedProtein BindingApolipoprotein A-IAryldialkylphosphataseLipoproteins, HDLPON1 protein, humanapolipoprotein A-Iclick chemistryhigh density lipoprotein (HDL)paraoxonase 1phospholipidphotoactivatable phospholipidphotoaffinity labelingpon1protein-lipid interactionprotein-lipid interactions

Identifiers

PMID26567339
PMCPMC4722466
OpenAlexW2176330652

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.